Patent details

Basic Information

Publication number:

EP3972960

PCT Application Number:

IB2020054752

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP207292012

PCT Publication Number:

WO2020234779

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE FORMS OF A BTK INHIBITOR

French Title of Invention:

FORMES CRISTALLINES D'UN INHIBITEUR DE BTK

German Title of Invention:

KRISTALLINE FORMEN EINES BTK-INHIBITORS

SPC Number:

Dates

Filing date:

20/05/2020

Grant date:

24/12/2025

EP Publication Date:

30/03/2022

PCT Publication Date:

26/11/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/12/2025

EP B1 Publication Date:

24/12/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

20/05/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/2025

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

KORDIKOWSKI, Andreas

Address:

Switzerland (CH)

2

Name:

ANGST, Daniela

Address:

Switzerland (CH)

Priority

Priority Number:

201962851986 P

Priority Date:

23/05/2019

Priority Country:

United States (US)

Classification

IPC classification:

C07D 239/47; A61P 35/00; A61K 31/505;

Publication

European Patent Bulletin

1

Issue number:

202552

Publication date:

24/12/2025

Description:

Grant (B1)

2

Issue number:

202605

Publication date:

28/01/2026

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

7

Annual Fee Amount:

82 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages